These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 27801830)

  • 1. The Expression and Clinical Outcome of pCHK2-Thr68 and pCDC25C-Ser216 in Breast Cancer.
    Jiang H; Wang B; Zhang F; Qian Y; Chuang CC; Ying M; Wang Y; Zuo L
    Int J Mol Sci; 2016 Oct; 17(11):. PubMed ID: 27801830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Different p53 genotypes regulating different phosphorylation sites and subcellular location of CDC25C associated with the formation of polyploid giant cancer cells.
    Liu K; Zheng M; Zhao Q; Zhang K; Li Z; Fu F; Zhang H; Du J; Li Y; Zhang S
    J Exp Clin Cancer Res; 2020 May; 39(1):83. PubMed ID: 32393310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of CDC25B, CDC25C and phospho-CDC25C (Ser216) in vulvar squamous cell carcinomas are associated with malignant features and aggressive cancer phenotypes.
    Wang Z; Trope CG; Flørenes VA; Suo Z; Nesland JM; Holm R
    BMC Cancer; 2010 May; 10():233. PubMed ID: 20500813
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PLK4 is a key molecule in the formation of PGCCs and promotes invasion and migration of progeny cells derived from PGCCs.
    Fu F; Chen L; Yang X; Fan L; Zhang M; Chen S; Zheng M; Gao M; Zhang S
    J Cancer; 2022; 13(9):2954-2969. PubMed ID: 35912011
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical Implications of TβRII Expression in Breast Cancer.
    Gao N; Zhai Q; Li Y; Huang K; Bian D; Wang X; Liu C; Xu H; Zhang T
    PLoS One; 2015; 10(11):e0141412. PubMed ID: 26551005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association and clinicopathologic significance of p38MAPK-ERK-JNK-CDC25C with polyploid giant cancer cell formation.
    Liu K; Lu R; Zhao Q; Du J; Li Y; Zheng M; Zhang S
    Med Oncol; 2019 Nov; 37(1):6. PubMed ID: 31734829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aberrant expression of DNA damage response proteins is associated with breast cancer subtype and clinical features.
    Guler G; Himmetoglu C; Jimenez RE; Geyer SM; Wang WP; Costinean S; Pilarski RT; Morrison C; Suren D; Liu J; Chen J; Kamal J; Shapiro CL; Huebner K
    Breast Cancer Res Treat; 2011 Sep; 129(2):421-32. PubMed ID: 21069451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined expression of aldehyde dehydrogenase 1A1 and β-catenin is associated with lymph node metastasis and poor survival in breast cancer patients following cyclophosphamide treatment.
    Sun M; Zhao H; Xiao Q; Yu Z; Song Z; Yao W; Tang H; Guan S; Jin F; Wei M
    Oncol Rep; 2015 Dec; 34(6):3163-73. PubMed ID: 26398662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased expression of microRNA-124 is an independent unfavorable prognostic factor for patients with breast cancer.
    Dong LL; Chen LM; Wang WM; Zhang LM
    Diagn Pathol; 2015 Apr; 10():45. PubMed ID: 25924779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SOX4 overexpression is a novel biomarker of malignant status and poor prognosis in breast cancer patients.
    Song GD; Sun Y; Shen H; Li W
    Tumour Biol; 2015 Jun; 36(6):4167-73. PubMed ID: 25592378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Study of the correlation between HER-2 gene and lymphangiogenesis and their prognostic significance in human breast cancer].
    Zhang GH; Yang WT; Zhou XY; Zeng Y; Lu HF; Shi DR
    Zhonghua Yi Xue Za Zhi; 2007 Jan; 87(3):155-60. PubMed ID: 17425844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation and prognostic value of SIRT1 and Notch1 signaling in breast cancer.
    Cao YW; Li WQ; Wan GX; Li YX; Du XM; Li YC; Li F
    J Exp Clin Cancer Res; 2014 Nov; 33(1):97. PubMed ID: 25420528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The clinical and prognostic significance of midkine in breast cancer patients.
    Li F; Tian P; Zhang J; Kou C
    Tumour Biol; 2015 Dec; 36(12):9789-94. PubMed ID: 26159850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA damage response-related proteins in gastric cancer: ATM, Chk2 and p53 expression and their prognostic value.
    Lee HE; Han N; Kim MA; Lee HS; Yang HK; Lee BL; Kim WH
    Pathobiology; 2014; 81(1):25-35. PubMed ID: 23969480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TIF1γ interferes with TGFβ1/SMAD4 signaling to promote poor outcome in operable breast cancer patients.
    Kassem L; Deygas M; Fattet L; Lopez J; Goulvent T; Lavergne E; Chabaud S; Carrabin N; Chopin N; Bachelot T; Gillet G; Treilleux I; Rimokh R
    BMC Cancer; 2015 Jun; 15():453. PubMed ID: 26040677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of Ubiquilin1 expression in invasive breast cancer.
    Wang Y; Lu J; Zhao X; Feng Y; Lv S; Mu Y; Wang D; Fu H; Chen Y; Li Y
    Cancer Biomark; 2015; 15(5):635-43. PubMed ID: 26406952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of Rsf-1 correlates with pathological type, p53 status and survival in primary breast cancer.
    Ren J; Chen QC; Jin F; Wu HZ; He M; Zhao L; Yu ZJ; Yao WF; Mi XY; Wang EH; Wei MJ
    Int J Clin Exp Pathol; 2014; 7(9):5595-608. PubMed ID: 25337201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T-cadherin association with clinicopathological features and prognosis in axillary lymph node-positive breast cancer.
    Kong DD; Yang J; Li L; Wang W; Chen YN; Wang SB; Zhou YZ
    Breast Cancer Res Treat; 2015 Feb; 150(1):119-26. PubMed ID: 25677746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic influence of cyclooxygenase-2 protein and mRNA expression in node-negative breast cancer patients.
    Sicking I; Rommens K; Battista MJ; Böhm D; Gebhard S; Lebrecht A; Cotarelo C; Hoffmann G; Hengstler JG; Schmidt M
    BMC Cancer; 2014 Dec; 14():952. PubMed ID: 25511800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Co-expression of parathyroid hormone related protein and TGF-beta in breast cancer predicts poor survival outcome.
    Xu C; Wang Z; Cui R; He H; Lin X; Sheng Y; Zhang H
    BMC Cancer; 2015 Nov; 15():925. PubMed ID: 26597083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.